MetaCap

Redhill Biopharma Statistics

NASDAQ: RDHLHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.281-0.0423 (-13.08%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Redhill Biopharma by the numbers

Redhill Biopharma has a market capitalization of $2.5 million based on 8.89M shares outstanding. With trailing EPS of $0.00, Redhill Biopharma is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 39.4% below its 50-day average and 62.3% below its 200-day average.

Average daily trading volume is 2.08M shares, or about $584,657 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RDHL valuation vs. peer median

RDHL compared with the median of 8 peer companies
MetricRDHLPeer medianDifference
Market cap$2.50M$2.41M+4%
Avg. volume2.08M396.14K+425%

Peer median across 8 companies: DRMA, GRI, ONCO, HCWB, MBIO, TRAW, ERNA, LABT.

Valuation

Price / sales (latest FY)
0.31

Price and trading

Previous close
0.3233
Open
0.3114
Day range
0.281 – 0.3385
52-week range
0.281 – 1.60
Beta
—
Volume
24.25K

Dividends and events

Annual dividend
None
Next earnings date
Apr 10, 2025

Additional statistics

Market Cap
2.50M
Forward Pe
9.37
Eps
0.00
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
1.60
Week52 Low
0.28
Avg Volume
2.08M
Shares Outstanding
8.89M
Ma50
0.46
Ma200
0.75
Earnings Date
Apr 10, 2025
Pct From52w High
-82.44%
Pct From52w Low
0.00%

Related